Results 171 to 180 of about 132,704 (355)

One-Year Pruritus Trends Among Patients Receiving Hemodialysis and Associated Outcomes [PDF]

, 2023
Kendra E. Wulczyn, David Steele
openalex   +1 more source

Skin disease in captive bats: results of an online survey of zoos and rehabilitators in Europe, North America and Australasia [PDF]

, 2017
Bello-Gutiérrez, Dickens, Gartrell, Goodnight, Kiefer, Madej, McGuire, Nagata, Olsson, Olsson, Park, Routh, Stringer, Tang, Weissenbacher-Lang, Wright   +15 more
core   +2 more sources

PRURITUS ANI [PDF]

BMJ, 1931
openaire   +2 more sources

Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background As Parkinson's disease (PD) progresses, motor fluctuations become increasingly difficult to manage with oral medications. Foslevodopa/foscarbidopa (LDp/CDp), delivered as a continuous 24‐h/day subcutaneous infusion, offers continuous levodopa delivery and stable plasma levodopa levels that reduce motor fluctuations. LDp/CDp has been
K. Ray Chaudhuri, Bruno Bergmans, Eric Freire‐Alvarez, Lucie Hopes, Drew S. Kern, Robert S. Kirsner, Giulia Lazzeri, Pedro Mendes‐Bastos, Noriko Nishikawa, Per Odin, Karolina Poplawska‐Domaszewicz, Rajesh Pahwa, Yuval Ramot, Klaus Seppi, Tobias Warnecke, Robert Wiggins, Megha B. Shah, Pavnit Kukreja, Bjoern Fritz, Koray Onuk, Stuart H. Isaacson   +20 more
wiley   +1 more source

Dementia Incidence in Patients With Prurigo Nodularis: An Observational Retrospective Cohort Study

JEADV Clinical Practice, EarlyView.
Madison P. Olexson, Ana Ormaza Vera, Chunghwan Ro, Clinton W. Enos   +3 more
wiley   +1 more source

Phase 3b Extension Study MT‐1186‐A04 to Evaluate the Continued Efficacy and Safety of Edaravone Oral Suspension for Up to an Additional 48 Weeks in Patients With Amyotrophic Lateral Sclerosis

Muscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims An On/Off dosing regimen of intravenous (IV) edaravone and edaravone oral suspension is currently approved in the US for treatment of amyotrophic lateral sclerosis (ALS). Placebo‐controlled clinical trials showed that IV edaravone slows physical functional decline.
Angela Genge, Jeffrey Rothstein, Shari De Silva, Lorne Zinman, Marvin Chum, Adriano Chiò, Gen Sobue, Masashi Aoki, Hiide Yoshino, Manabu Doyu, Daniel Selness, Vesna Todorovic, Manabu Hirai, Nissim Sasson, Fumihiro Takahashi, Michelle Cecić, Art Wamil, Stephen Apple   +17 more
wiley   +1 more source

Therapeutics in chronic pruritus of unknown origin

, 2023
Teresa Ju, Angelina Labib, Ashley Vander Does, Gil Yosipovitch   +3 more
openalex   +1 more source

Radiofrequency Ablation Versus Laser Neurolysis of the Posterior Nasal Nerve in Patients With Chronic Rhinitis

Otolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective To compare the clinical outcomes of radiofrequency ablation of the intraturbinate segment of the posterior nasal nerve (RAPN) alone versus combined RAPN with CO₂ laser posterior nasal nerve neurolysis (RPN3) in patients with chronic rhinitis refractory to medical therapy. Study Design Retrospective cohort study.
Chia‐Chen Lin, Yi‐Li Hwang, Jyun‐Yi Liao, Han‐Lo Teng, Ting‐Yu Shih, Chien‐Yu Huang   +5 more
wiley   +1 more source

Evaluation of serum levels of neurotrophin 4 and brain-derived nerve growth factor in uremic pruritus patients

Clinical, Cosmetic and Investigational Dermatology, 2019
Neveen E Sorour,1 Fatma M Elesawy,1 Hala A Tabl,2 Mohammed E Ibrahim,3 Essam M Akl1 1Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Benha University, Benha, Egypt; 2Department of Microbiology and Immunology, Faculty of ...
Sorour NE, Elesawy FM, Tabl HA, Ibrahim ME, Akl EM   +4 more
doaj  

Pruritus bei Kindern [PDF]

, 2008
Sonja Ständer
openalex   +1 more source